Drug shortage
Memantine Hydrochloride Tablet · Actavis Pharma, Inc.
FDA drug shortage · To Be Discontinued · updated Nov 21, 2024
Key facts
| Generic name | Memantine Hydrochloride Tablet |
|---|---|
| Proprietary name | Namenda |
| Company | Actavis Pharma, Inc. |
| Presentation | Namenda, Tablet, 5 mg (NDC 0591-3870-44) |
| Dosage form | Tablet |
| Strength | 5 mg |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 0591-3870-44 |
| First posted | Nov 21, 2024 |
| Last updated | Nov 21, 2024 |
| Discontinued | Nov 21, 2024 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: